Aortic Valve Stenosis

BOSTON — Changes in devices and procedural care were the biggest factor in improvements in short-term outcomes for patients undergoing transcatheter aortic valve replacement, researchers reported at TCT 2022.

BOSTON — Transcatheter aortic valve replacement with the self-expanding Acurate neo device was similar to the balloon-expandable Sapien 3 device in clinical outcomes at 3 years, according to new data from the SCOPE I trial.

In a large, real-world cohort undergoing routine echocardiography, an artificial intelligence decision-support algorithm identified patients with moderate to severe forms of aortic stenosis associated with poor survival if left untreated.

Patients with left ventricular outflow tract calcification who underwent transcatheter aortic valve replacement did not have elevated risk for poor short- and midterm clinical outcomes, according to new data from the SOLVE-TAVI trial.

Norton score upon admission is a marker of short‐ and long‐term mortality and should be considered as a risk stratification tool for adults who are candidates for surgical aortic valve replacement, researchers reported.

A next-generation transcatheter aortic valve replacement system was associated with less paravalvular aortic regurgitation compared with an earlier version, researchers reported at EuroPCR.

The Society for Cardiovascular Angiography and Interventions published its recommendations for percutaneous placement of large-bore arterial sheaths and devices specifically via transaxillary arterial access.

WASHINGTON — There have been many changes in intervention since Alain Cribier, MD, FASC, FESC, performed the first-in-human transcatheter aortic valve replacement in a patient with severe aortic stenosis who was not a candidate for surgery.

WASHINGTON — The 5-year rate of structural valve deterioration was lower in self-expanding valves for transcatheter aortic valve replacement than in surgical valves, researchers reported.

Among adults with severe aortic stenosis who underwent transcatheter aortic valve replacement, those who received prior chest radiation therapy experienced no differences in clinical outcomes compared with those who did not, data show.